Fusidic acid is an effective treatment against Toxoplasma gondii and Listeria monocytogenes in vitro, but not in mice

作者: Amanda J. Payne , Lori M. Neal , Laura J. Knoll

DOI: 10.1007/S00436-013-3574-1

关键词:

摘要: Fusidic acid is a bacteriostatic antibiotic that inhibits the growth of bacteria by preventing release translation elongation factor G (EF-G) from ribosome. The apicomplexan parasite Toxoplasma gondii has an orthologue bacterial EF-G can complement and necessary for virulence. been shown to be effective in tissue culture against related pathogen Plasmodium falciparum, current drug treatments T. are limited. We therefore investigated therapeutic value fusidic found was culture, but not mouse model infection. To determine whether this trend would occur another intracellular elicits T helper 1-type immune response, we tested efficacy bacterium Listeria monocytogenes. Similar its effects on gondii, L. monocytogenes vitro, mice. These findings highlight necessity vivo follow-up studies validate vitro investigations.

参考文章(14)
P. L. Meroni, A. Santoni, R. Di Marco, K. Bendtzen, G. Magro, G. Tempera, S. Morrone, S. Grasso, F. Nicoletti, P. Zaccone, Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology. ,vol. 85, pp. 645- 650 ,(1995)
A Forsgren, A Bellahsène, Effect of fusidic acid on the immune response in mice. Infection and Immunity. ,vol. 29, pp. 873- 878 ,(1980) , 10.1128/IAI.29.3.873-878.1980
Tadatoshi Kinoshita, Genji Kawano, Nobuo Tanaka, Association of fusidic acid sensitivity with G factor in a protein-synthesizing system Biochemical and Biophysical Research Communications. ,vol. 33, pp. 769- 773 ,(1968) , 10.1016/0006-291X(68)90226-X
Peter Collignon, John Turnidge, Fusidic acid in vitro activity. International Journal of Antimicrobial Agents. ,vol. 12, ,(1999) , 10.1016/S0924-8579(98)00073-9
FinnT. Black, IngerLouise Wildfang, Karen Borgbjerg, Activity of fusidic acid against Plasmodium falciparum in vitro. The Lancet. ,vol. 325, pp. 578- 579 ,(1985) , 10.1016/S0140-6736(85)91234-6
Tareq M. Osaili, Anas A. Al-Nabulsi, Mohammad H. Taha, Murad A. Al-Holy, Akram R. Alaboudi, Walid M. Al-Rousan, Reyad R. Shaker, Occurrence and Antimicrobial Susceptibility ofListeria monocytogenesIsolated from Brined White Cheese in Jordan Journal of Food Science. ,vol. 77, pp. M528- M532 ,(2012) , 10.1111/J.1750-3841.2012.02877.X
Crystal M. Tobin, Laura J. Knoll, A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner. Infection and Immunity. ,vol. 80, pp. 55- 61 ,(2012) , 10.1128/IAI.05543-11
John Turnidge, Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. International Journal of Antimicrobial Agents. ,vol. 12, ,(1999) , 10.1016/S0924-8579(98)00071-5
Carl N. Kraus, Barry W. Burnstead, The safety record of fusidic acid in non-US markets: a focus on skin infections. Clinical Infectious Diseases. ,vol. 52, ,(2011) , 10.1093/CID/CIR168
L. ROWE, G. FINDON, T. E. MILLER, An experimental evaluation of the pharmacokinetics of fusidic acid in peritoneal dialysis. Journal of Medical Microbiology. ,vol. 36, pp. 71- 77 ,(1992) , 10.1099/00222615-36-2-71